For research use only. Not for therapeutic Use.
Depramine (Cat.No:I025907) is a tricyclic antidepressant that acts by inhibiting the reuptake of serotonin and norepinephrine in the brain. It is primarily used in the treatment of depression and anxiety disorders. Depramine helps to restore the balance of neurotransmitters, alleviating symptoms and improving mood.
| Catalog Number | I025907 |
| CAS Number | 303-54-8 |
| Synonyms | Balipramine; Depramine; GP31406; GP-31406; GP 31406 |
| Molecular Formula | C19H22N2 |
| Purity | ≥95% |
| Target | Cholinesterase (ChE) |
| Solubility | Soluble in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
| IUPAC Name | 3-benzo[b][1]benzazepin-11-yl-N,N-dimethylpropan-1-amine |
| InChI | InChI=1S/C19H22N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-13H,7,14-15H2,1-2H3 |
| InChIKey | AFBYHZACPPSJKD-UHFFFAOYSA-N |
| SMILES | CN(C)CCCN1C2=CC=CC=C2C=CC3=CC=CC=C31 |
| Reference | 1. Oscar-Berman M, Gade A, Feldman RG, Saavedra MA. Effects of dimepramine fumarate on physiological and cognitive behaviors of Parkinson patients. J Clin Pharmacol. 1979 Oct;19(10):626-34. doi: 10.1002/j.1552-4604.1979.tb01625.x. PMID: 512060. |
